Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Nakayama

Showing results (21-30 of 174) with videos related to

Pageof 18
Sort By:
Healthcare (Basel, Switzerland)|December 23, 2020
Prevalence and Associated Factors of Malnutrition and Sarcopenia in a Daycare Facility: A Cross-Sectional StudyAya Shiota, Naomi Nakayama, Yuki Saito, et al.
Oncology|July 26, 2002
Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancerKohkichi Hata, Jun Udagawa, Ritsuto Fujiwaki, et al.
Frontiers in Oncology|April 2, 2026
Determinants of skeletal muscle loss during initial treatment in patients with ovarian cancer: a brief reportNaomi Nakayama, Daisaku Asai, Tomoka Ishibashi, et al.
International Journal of Molecular Medicine|April 10, 2003
Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapySatoru Nakayama, Kentaro Nakayama, Yuji Takebayashi, et al.
Anticancer Research|February 26, 2004
The proliferative activity of ovarian tumors of low malignant potential differs from that of ovarian carcinomaKentaro Nakayama, Yuji Takebayashi, Kohkichi Hata, et al.
Cancer|March 26, 2010
Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancerNaomi Nakayama, Kentaro Nakayama, Yeasmin Shamima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 20, 2008
[Two cases of endometrial stromal sarcoma (ESS) in which survival was prolonged by administration of MPA]Masako Ishibashi, Kentaro Nakayama, Yeasmin Shamima, et al.
Oncotarget|March 22, 2018
Reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cellsKohei Nakamura, Kentaro Nakayama, Noriyoshi Ishikawa, et al.
Molecular and Clinical Oncology|April 2, 2025
Outcomes and patterns of recurrence of robot‑assisted or laparoscopic radical hysterectomy in early‑stage cervical cancerMasako Ishikawa, Kentaro Nakayama, Tomoka Ishibashi, et al.
International Journal of Oncology|April 8, 2010
NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinomaMasako Ishikawa, Kentaro Nakayama, Shamima Yeasmin, et al.
Pageof 18

Showing results (21-30 of 174) with videos related to

Sort By:
Pageof 18
Healthcare (Basel, Switzerland)|December 23, 2020
Prevalence and Associated Factors of Malnutrition and Sarcopenia in a Daycare Facility: A Cross-Sectional StudyAya Shiota, Naomi Nakayama, Yuki Saito, et al.
Oncology|July 26, 2002
Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancerKohkichi Hata, Jun Udagawa, Ritsuto Fujiwaki, et al.
Frontiers in Oncology|April 2, 2026
Determinants of skeletal muscle loss during initial treatment in patients with ovarian cancer: a brief reportNaomi Nakayama, Daisaku Asai, Tomoka Ishibashi, et al.
International Journal of Molecular Medicine|April 10, 2003
Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapySatoru Nakayama, Kentaro Nakayama, Yuji Takebayashi, et al.
Anticancer Research|February 26, 2004
The proliferative activity of ovarian tumors of low malignant potential differs from that of ovarian carcinomaKentaro Nakayama, Yuji Takebayashi, Kohkichi Hata, et al.
Cancer|March 26, 2010
Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancerNaomi Nakayama, Kentaro Nakayama, Yeasmin Shamima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 20, 2008
[Two cases of endometrial stromal sarcoma (ESS) in which survival was prolonged by administration of MPA]Masako Ishibashi, Kentaro Nakayama, Yeasmin Shamima, et al.
Oncotarget|March 22, 2018
Reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cellsKohei Nakamura, Kentaro Nakayama, Noriyoshi Ishikawa, et al.
Molecular and Clinical Oncology|April 2, 2025
Outcomes and patterns of recurrence of robot‑assisted or laparoscopic radical hysterectomy in early‑stage cervical cancerMasako Ishikawa, Kentaro Nakayama, Tomoka Ishibashi, et al.
International Journal of Oncology|April 8, 2010
NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinomaMasako Ishikawa, Kentaro Nakayama, Shamima Yeasmin, et al.
Pageof 18